Please scroll to read. Once you have completed reviewing, click “Continue” below.
Temporary Updates to the Terms and Conditions for the Merck Co-pay Assistance Program - ZINPLAVA™ (bezlotoxumab) Injection 25 mg/mL
EFFECTIVE 06/01/2020 – 05/31/2021:
All other Terms and Conditions for The Merck Co-Pay Assistance Program remain in effect and must be satisfied to receive the benefit. If you have any questions, please contact The Merck Access Program at 877-709-4455 from 8 AM to 8 PM ET, Monday through Friday.
Terms and Conditions for the Co-pay Assistance Program for ZINPLAVA™ (bezlotoxumab) Injection 25 mg/mL:
Merck’s Response to Coronavirus (COVID-19)
During this unprecedented time, Merck is committed to ensuring our medicines reach our patients and customers. If you have concerns that you may have lost your insurance coverage due to the COVID-19 pandemic or may not be able to afford your medication, we encourage you to call The Merck Access Program.
For more details about Merck’s response to coronavirus, visit our COVID-19 information page.
Now Available: Electronic Enrollment Form with E-Signature